{
    "title": "Cancer Therapy",
    "inventor_name": "Christine Dufes",
    "publication_year": 2008,
    "device_name": "Cationic Polyamine/Dendrimer Anti-Cancer Polymer Therapy",
    "goal": "Eradicate tumours without causing harmful side-effects",
    "problem_addressed": "Uncontrolled cellular proliferation (cancer tumours)",
    "concept_summary": "The invention uses cationic polyamine polymers and dendrimeric polymers that possess intrinsic anti-proliferative activity and can also serve as delivery vehicles for therapeutic DNA or proteins. Targeted delivery is achieved via transferrin-mediated transport or hyaluronic-acid conjugation to CD44 receptors, leading to tumour cell apoptosis and tumour regression in animal models.",
    "detailed_description": null,
    "category": "Medical & Dental Technologies",
    "principles": [
        "Intrinsic anti-proliferative activity of cationic polymers",
        "Targeted delivery via transferrin receptor binding",
        "Gene therapy using plasmid DNA encoding therapeutic proteins",
        "Dendrimer-mediated gene transfection and drug delivery"
    ],
    "scientific_domains": [
        "Pharmacology",
        "Molecular Biology",
        "Nanotechnology"
    ],
    "mechanisms_of_action": [
        "Induction of apoptosis in tumour cells",
        "Inhibition of tumour cell proliferation",
        "DNA delivery to tumour cells via transferrin or dendrimer carriers",
        "Targeted binding to CD44 receptors using hyaluronic-acid conjugates"
    ],
    "materials": [
        "Cationic polyamine polymers",
        "Polypropylenimine dendrimers (e.g., DAB16)",
        "PAMAM dendrimers",
        "Linear polyethylenimine (PEI)",
        "Transferrin protein",
        "Plasmid DNA encoding TNF-alpha",
        "Hyaluronic acid",
        "Iron (carrier in transferrin)"
    ],
    "energy_sources": [],
    "inputs": [
        "Tumour cells",
        "Therapeutic plasmid DNA",
        "Transferrin protein"
    ],
    "outputs": [
        "Tumour reduction or complete disappearance",
        "Anti-proliferative effect"
    ],
    "claimed_performance": "Complete tumour disappearance within 10 days in mouse models; significant inhibition of tumour growth in multiple xenograft studies.",
    "experimental_evidence": "In vivo mouse xenograft experiments showing tumour volume reduction, complete response in some groups, and minimal body-weight loss, supporting anti-tumour activity of the polymers and their complexes.",
    "replication_status": null,
    "keywords": [
        "cancer therapy",
        "polymer",
        "dendrimer",
        "gene delivery",
        "transferrin",
        "anti-proliferative",
        "nanomedicine"
    ],
    "related_technologies": [
        "Gene therapy",
        "Nanoparticle drug delivery",
        "Targeted protein carriers"
    ],
    "controversy_level": "low",
    "confidence_score": 0.85,
    "practicability_score": 0.6,
    "fringe_score": 0.2,
    "evidence_strength": 0.6,
    "risk_score": 0.3,
    "trl_estimate": 4,
    "source_urls": [
        "http://www.heraldscotland.com/news/health/scientists-make-cancer-cells-vanish-1.1022114",
        "http://freepressinternational.com/2010/04/scientists-make-cancer-cells-vanish/"
    ],
    "organizations": [
        "University of Strathclyde",
        "University of Glasgow",
        "Tenovus Scotland"
    ],
    "applications": [
        "Cancer treatment",
        "Anti-proliferative therapy"
    ],
    "limitations": [
        "Evidence limited to pre-clinical animal models",
        "Potential toxicity of cationic polymers",
        "Delivery efficiency and targeting specificity not yet proven in humans"
    ],
    "open_questions": [
        "Long-term safety and immunogenicity in humans",
        "Scalability and manufacturing of bioactive polymers",
        "Effectiveness across diverse tumour types and stages"
    ],
    "red_flags": [
        "Potential cytotoxicity of cationic polymers",
        "Claims of complete tumour disappearance without clinical trial data"
    ],
    "evidence_quotes": [
        "The tumours were completely gone within 10 days.",
        "DAB16 polymer as a single agent delayed long-term tumour growth.",
        "HA-dendrimer can target cancer cells expressing the CD44 receptor.",
        "In vitro cytostatic effects induced by various polymers.",
        "Body weight change in treated mice showed minimal toxicity."
    ]
}